| 518 |
Centers for Disease Control and Prevention |
Html |
en |
Who Should not Get Vaccinated | CDC |
Who should NOT Get Vaccinated? |
| Tdap vaccine | 0.296381 |
| health care provider | 0.303789 |
| pregnant women | 0.330075 |
| severe allergies | 0.466563 |
| severe allergic reaction | 0.26589 |
| yellow fever vaccine | 0.318971 |
| anthrax vaccine | 0.334159 |
| vaccine tablets | 0.32473 |
| varicella vaccine | 0.304879 |
| influenza vaccine | 0.306793 |
| chickenpox vaccine | 0.331419 |
| meningococcal ACWY vaccine | 0.315099 |
| hepatitis A vaccine | 0.311034 |
| shingles vaccine | 0.323926 |
| rabies vaccine | 0.305912 |
| severe allergy | 0.530001 |
| typhoid vaccine | 0.324579 |
| life-threatening allergic reaction | 0.881751 |
| dose | 0.448739 |
| person | 0.306382 |
| previous dose | 0.425582 |
| pertussis vaccine | 0.311969 |
| earlier pneumococcal vaccine | 0.313353 |
| meningococcal vaccine | 0.302052 |
|
| vaccine components | 0.335066 |
| rotavirus vaccine | 0.318984 |
| JE vaccine | 0.313262 |
| flu vaccine | 0.329162 |
| HPV vaccine | 0.329971 |
| life-threatening allergies | 0.298336 |
| MMRV vaccine | 0.339147 |
| vaccine virus | 0.318866 |
| mild illness | 0.373388 |
| severe reaction | 0.2539 |
| Td vaccine | 0.296862 |
| hepatitis B vaccine | 0.310235 |
| Hib vaccine | 0.331618 |
| vaccine component | 0.319792 |
| DTaP vaccine | 0.313751 |
| people | 0.284121 |
| doctor | 0.37372 |
| vaccine | 0.98629 |
| Live typhoid vaccine | 0.30615 |
| antibiotic neomycin | 0.263282 |
| cancer | 0.252495 |
| adenovirus vaccine | 0.322799 |
| Oral typhoid vaccine | 0.309821 |
| MMR vaccine | 0.325788 |
|
CLICK HERE |
| 4680 |
Centers for Disease Control and Prevention |
Html |
en |
Rotavirus Homepage |
Rotavirus website home page |
| contagious virus | 0.294783 |
| risk factors | 0.271215 |
| available rotavirus vaccines | 0.801821 |
| Download CDC | 0.30592 |
| CDC surveillance systems | 0.455106 |
| Web feature | 0.268138 |
| rotavirus disease | 0.940593 |
| severe watery diarrhea | 0.426684 |
|
| scientific articles | 0.269838 |
| rotavirus burden | 0.751588 |
| CDC manuals | 0.309797 |
| abdominal pain | 0.267352 |
| rotavirus | 0.989194 |
| young children | 0.251847 |
| mobile app | 0.295246 |
|
CLICK HERE |
| 8179 |
Centers for Disease Control and Prevention |
Html |
en |
Muscular Dystrophy - Free Materials |
null |
| Becker muscular dystrophy | 0.539341 |
| Becker Muscular Dystrophies | 0.467862 |
| physical therapists | 0.32646 |
| Duchenne Muscular Dystrophy-A | 0.470297 |
| CDC | 0.305911 |
| American Medical Association | 0.346731 |
| JAMA Patient Page | 0.346776 |
| students | 0.305077 |
| oculopharyngeal muscular dystrophies | 0.47624 |
| family-friendly clinical care | 0.349091 |
| Information | 0.317341 |
| life | 0.305714 |
| limb-girdle muscular dystrophy | 0.568476 |
| congenital muscular dystrophy | 0.587692 |
| muscular dystrophy | 0.92485 |
| Public Health Challenge | 0.356137 |
| fact sheet | 0.416316 |
| ways | 0.30573 |
| facioscapulohumeral muscular dystrophy | 0.740323 |
| Girdle Muscular Dystrophies | 0.471423 |
| fact sheet outlines | 0.34471 |
| teachers | 0.305092 |
|
| Diagnosis | 0.304955 |
| Duchenne Muscular Dystrophy | 0.552941 |
| muscular dystrophies | 0.515055 |
| Schools | 0.305121 |
| guide | 0.321297 |
| school personnel | 0.328124 |
| overview | 0.309974 |
| patients | 0.305002 |
| FSHD | 0.307454 |
| Rare Muscular Dystrophies | 0.479707 |
| families | 0.324281 |
| people | 0.30571 |
| Muscular Dystrophy Association | 0.67291 |
| limb-girdle muscular dystrophies | 0.47829 |
| individualized plan | 0.328008 |
| Facts | 0.320068 |
| quality | 0.305718 |
| myotonic muscular dystrophy | 0.561893 |
| Researchers | 0.305743 |
| Physical Therapy | 0.327704 |
| distal muscular dystrophy | 0.586986 |
|
CLICK HERE |
| 8894 |
Centers for Disease Control and Prevention |
Html |
en |
Malaria - Malaria Worldwide |
Information on global malaria programs, malaria's impact, and how to reduce malaria's impact in the world as well as CDC's global activities. |
| decade | 0.426025 |
| malaria—most | 0.42474 |
| CDC | 0.512676 |
| numbers | 0.424456 |
| individuals | 0.421292 |
| vulnerable groups | 0.529665 |
| pregnant women | 0.52663 |
| weak infrastructure | 0.519809 |
| control interventions | 0.522064 |
| young children | 0.660784 |
| lives | 0.422921 |
| pregnancy | 0.421509 |
| scale-up | 0.475395 |
| malaria control efforts | 0.855948 |
| deadly species | 0.521528 |
| high transmission | 0.51937 |
| poor countries | 0.516716 |
| global support | 0.513665 |
| eradication | 0.42754 |
| plans | 0.422819 |
| malaria landscape | 0.68508 |
| technical expertise | 0.642552 |
| malaria-endemic countries | 0.627462 |
| high intervention costs | 0.611654 |
| efficient mosquito | 0.520729 |
|
| death | 0.421918 |
| malaria mortality | 0.727765 |
| immunity | 0.455313 |
| malaria | 0.99729 |
| largest burden | 0.527507 |
| policy development | 0.519047 |
| sub-Saharan Africa | 0.545327 |
| world | 0.422455 |
| program guidance | 0.516062 |
| hopes | 0.424988 |
| collaborative work | 0.527415 |
| elimination | 0.425307 |
| subtropical areas | 0.533594 |
| Roll Back Malaria | 0.689435 |
| national commitment | 0.516748 |
| scientific research | 0.51534 |
| long history | 0.514765 |
| resources | 0.424425 |
| high prevalence | 0.520412 |
| families | 0.421278 |
| people | 0.424763 |
| parasite | 0.422406 |
| partners | 0.444962 |
| favorable climate | 0.52016 |
|
CLICK HERE |
| 11990 |
Centers for Disease Control and Prevention |
Html |
en |
Wholesome Soy Products, Inc. Sprouts Recall and Investigation of Human Listeriosis Cases |
null |
| voluntary recall | 0.25437 |
| Listeria strains | 0.288534 |
| finished product | 0.23171 |
| human illness | 0.232291 |
| Public health investigators | 0.25217 |
| mung bean sprouts | 0.656842 |
| numerous unsanitary conditions | 0.260358 |
| Soy Products Inc. | 0.27857 |
| firm | 0.236867 |
| Inc. | 0.305831 |
| Listeria Web Page | 0.285636 |
| Listeria strain | 0.25413 |
| U.S. Food | 0.232074 |
| inspectional observations | 0.273795 |
| inspection findings | 0.245606 |
| irrigation water samples | 0.258894 |
| clearer distinction | 0.2332 |
| Wholesome Soy Products | 0.943186 |
| previous inspection | 0.231992 |
| Listeria monocytogenes | 0.426796 |
| sprout consumption history | 0.293097 |
| highly related strains | 0.252775 |
| pulsed-field gel electrophoresis | 0.259138 |
| genetic similarity | 0.231348 |
| high degree | 0.233119 |
|
| national subtyping network | 0.259234 |
| ill people | 0.304034 |
| FDA | 0.300296 |
| genome sequencing findings | 0.286371 |
| production | 0.264191 |
| United States | 0.23277 |
| consuming bean sprouts | 0.280829 |
| Drug Administration | 0.234885 |
| poor equipment maintenance | 0.331017 |
| soy bean sprouts | 0.296499 |
| important cause | 0.232406 |
| environmental swabs | 0.265469 |
| FDA investigators | 0.233753 |
| possible Listeria monocytogenes | 0.271013 |
| public health | 0.277212 |
| food safety practices | 0.231688 |
| environmental samples | 0.257646 |
| specific sprout products | 0.289333 |
| CDC Listeria Web | 0.283839 |
| contaminated sprouts | 0.239117 |
| common source | 0.233114 |
| unsanitary conditions | 0.304493 |
| routine assignment | 0.256381 |
| facility | 0.265778 |
|
CLICK HERE |
| 12060 |
Centers for Disease Control and Prevention |
Html |
en |
Resources for Parents, Schools, and Pediatric Healthcare Professionals | Ebola Hemorrhagic Fever |
null |
| practice | 0.421349 |
| rare disease | 0.526718 |
| CDC | 0.457366 |
| United States | 0.526551 |
| appropriate care | 0.521684 |
| adults | 0.472158 |
| Early Head Start | 0.619163 |
| Child Care Providers | 0.619794 |
| school administrators | 0.525377 |
| funeral rituals | 0.537617 |
| pediatric patients | 0.516507 |
| social needs | 0.532181 |
| Ebola outbreak | 0.764253 |
| public health departments | 0.635499 |
| caregivers | 0.423993 |
| unique physical | 0.532376 |
| children | 0.641035 |
| mental health needs | 0.844366 |
| procedures | 0.421327 |
| K-12 schools | 0.52546 |
| case fatality rates | 0.667292 |
| special mental health | 0.640144 |
|
| place | 0.421312 |
| following publications | 0.525444 |
| news | 0.423015 |
| impact | 0.421138 |
| sick people | 0.538893 |
| Tools | 0.444344 |
| resources | 0.445502 |
| staff | 0.421195 |
| high risk activities | 0.64289 |
| local health officials | 0.621405 |
| concerns | 0.447645 |
| steps | 0.421121 |
| friends | 0.422985 |
| fewer children | 0.555977 |
| Ebola-related decisions | 0.523315 |
| School officials | 0.521143 |
| chances | 0.42535 |
| healthcare workers | 0.530007 |
| past outbreaks | 0.545652 |
| information | 0.471659 |
| appropriate state | 0.523109 |
| Ebola | 0.974979 |
|
CLICK HERE |
| 12226 |
Centers for Disease Control and Prevention |
Html |
en |
Hand Foot and Mouth Disease | Overview of HFMD |
About hand, foot, and mouth disease: causes, signs and symptoms, diagnosis, treatment, prevention and complications. |
| MPEG | 0.343402 |
| viruses | 0.345358 |
| different file formats | 0.596455 |
| symptoms | 0.33893 |
| mouth disease | 0.989459 |
| signs | 0.339029 |
| PDF | 0.332008 |
|
| PPT | 0.355091 |
| DOC | 0.341556 |
| health care providers | 0.593979 |
| foot | 0.499873 |
| hand | 0.500402 |
| health complications | 0.479813 |
|
CLICK HERE |
| 13222 |
Centers for Disease Control and Prevention |
Video |
en |
Ebola: Getting to Zero |
Progress has been made in the year since CDC first responded to the Ebola outbreak in West Africa, but CDC’s and the world’s efforts must continue until there are zero new cases.
Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html
This video can also be viewed at
http://www.cdc.gov/media/video/dpk/2015/dpk-getting-to-zero/GettingToZero-Long%20embedded.wmv |
|
|
CLICK HERE |
| 13588 |
Centers for Disease Control and Prevention |
Html |
en |
Vital Signs: Predicted Heart Age and Racial Disparities inHeart Age Among U.S. Adults at the State Level |
Please note: An erratum has been published for this article. To view the erratum, please click here. |
| predicted excess heart | 0.393223 |
| United States | 0.355517 |
| risk score | 0.36613 |
| heart age calculation | 0.373977 |
| Risk Factor Surveillance | 0.362765 |
| chronological age | 0.474297 |
| additional CVD risk | 0.36785 |
| heart age versus | 0.365173 |
| systolic blood pressure | 0.587976 |
| long-term CVD risk | 0.375299 |
| CVD risk factor | 0.364919 |
| risk factor profile | 0.361372 |
| lifestyle changes | 0.368496 |
| excess heart age | 0.824441 |
| geographic CVD disparities | 0.358673 |
| CVD risk | 0.535998 |
| men | 0.365617 |
| predicted systolic blood | 0.367565 |
| participants | 0.35473 |
| higher predicted heart | 0.403929 |
| non–laboratory-based framingham risk | 0.363449 |
| CVD prediction models | 0.356162 |
| FRS heart age | 0.370846 |
|
| framingham risk score | 0.363447 |
| U.S. adults | 0.42738 |
| different predicted risk | 0.362846 |
| elevated heart age | 0.364478 |
| modifiable CVD risk | 0.376906 |
| CVD risk levels | 0.365863 |
| cardiovascular risk factor | 0.388576 |
| mean excess heart | 0.372877 |
| household income | 0.385878 |
| absolute CVD risk | 0.38462 |
| 10-year CVD risk | 0.366453 |
| age-standardized excess heart | 0.363989 |
| excess heart ages | 0.364796 |
| mean chronological age | 0.353092 |
| sex-specific non–laboratory-based Framingham | 0.353733 |
| coronary heart disease | 0.372337 |
| average excess heart | 0.360556 |
| traditional absolute CVD | 0.354184 |
| Behavioral Risk Factor | 0.362801 |
| CVD risk factors | 0.505337 |
| heart age | 0.947757 |
| BRFSS participants | 0.352945 |
| women | 0.370768 |
|
CLICK HERE |
| 14496 |
Centers for Disease Control and Prevention |
Html |
en |
Notes from the Field: Expanded Chemoprophylaxis Offered inResponse to a Case of Meningococcal Meningitis in an ElementarySchool - Indiana, 2015 | MMWR |
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). |
| minimal school disruption | 0.77653 |
| local health partnerships | 0.806531 |
| Human Services | 0.766144 |
| state health officials | 0.823639 |
| U.S. Department | 0.771693 |
| school faculty members | 0.781842 |
| possible exposures | 0.705262 |
| electronic PDF version | 0.760174 |
| meningococcal chemoprophylaxis | 0.749863 |
| health care providers | 0.956086 |
| Fort Wayne-Allen County | 0.805257 |
| immediate adverse events | 0.762185 |
| adult contacts | 0.72063 |
| 2Epidemiology Resource Center | 0.758527 |
| peripheral event contacts | 0.788264 |
| Stacey W. Martin | 0.758276 |
| Indiana State Department | 0.78093 |
| previous public health | 0.803257 |
| chemoprophylaxis clinic | 0.733343 |
| Gram stain results | 0.794352 |
| close household contacts | 0.799329 |
| elementary school | 0.796098 |
| local nonprofit hospital | 0.791856 |
| meningococcal disease | 0.739143 |
| persons | 0.700022 |
|
| cerebrospinal fluid | 0.704456 |
| minimal disruption | 0.702653 |
| county health department | 0.986466 |
| short time frame | 0.757678 |
| appropriate chemoprophylaxis | 0.708297 |
| Neisseria meningitidis serogroup | 0.784045 |
| original MMWR paper | 0.765862 |
| infectious period | 0.70163 |
| group receive antibiotics | 0.757839 |
| public health recommendations | 0.818892 |
| local hospital laboratory | 0.81634 |
| well-defined target group | 0.763395 |
| health care workers | 0.81528 |
| appropriate dosages | 0.701556 |
| ciprofloxacin oral suspension | 0.808863 |
| Parkview Regional Medical | 0.77553 |
| Wayne-Allen County Department | 0.781805 |
| CDC support | 0.737137 |
| meningococcal meningitis | 0.834053 |
| elementary school–aged children | 0.784862 |
| potential drug interactions | 0.767983 |
| potentially face-to-face contact | 0.781223 |
| close family members | 0.809387 |
| close contacts | 0.721301 |
|
CLICK HERE |